The Rezūm Procedure for Prostate Treatment: A Urologist’s Approach to Managing BPH in Patients with Cardiac Comorbidities
Introduction
Benign Prostatic Hyperplasia (BPH) is a common condition among aging men that can significantly affect quality of life, causing symptoms such as frequent urination, nocturia, and weak urinary stream. In managing BPH, especially in patients with comorbid conditions like cardiovascular disease, it is essential to balance the treatment options carefully to minimize risks and optimize outcomes. In today’s blog, I will discuss the Rezūm procedure—a minimally invasive treatment for BPH—and share insights from a recent case I managed: a 63-year-old male with cardiac disease.
Understanding BPH and Its Impact on Patients with Cardiac Disease
BPH involves the enlargement of the prostate gland, which can obstruct the flow of urine. If left untreated, BPH can lead to complications such as urinary retention and renal impairment. For patients with comorbidities like coronary artery disease (CAD), hypertension, or other heart conditions, medical management with medications may not always be sufficient or may present additional risks due to side effects.
In patients with cardiac disease, it’s particularly important to avoid treatments that can exacerbate their condition, such as medications that could affect blood pressure or cause fluid retention. For these patients, a minimally invasive surgical option like the Rezūm procedure offers a safe and effective solution.
What is the Rezūm Procedure?
The Rezūm procedure utilizes water vapor therapy to treat BPH. This minimally invasive technique involves the targeted delivery of steam into the prostate tissue, causing the tissue to shrink and the obstruction to reduce, thus alleviating symptoms. Key points of the procedure include:
- Water Vapor Therapy: Steam is delivered directly into the prostate, causing the enlarged tissue to shrink, leading to improved urinary flow.
- Minimally Invasive: The procedure is performed under local anesthesia, with no incisions or cuts required, making it an ideal choice for older patients or those with comorbidities.
- Reduced Risk: Compared to traditional surgeries like Transurethral Resection of the Prostate (TURP) or prostatectomy, Rezūm has a lower risk of complications like bleeding, which is particularly important in patients with cardiovascular disease.
Case Overview
In my recent case, I treated a 63-year-old male who had a history of coronary artery disease (CAD), controlled hypertension, and other cardiovascular risk factors. He presented with moderate to severe BPH symptoms, including nocturia, weak urinary stream, and difficulty in fully emptying his bladder. Due to his cardiac condition and potential surgical risks, I determined that he was not a suitable candidate for more invasive procedures like TURP.
After discussing various options with the cardiology and nephrology teams, we opted for the Rezūm procedure. This decision was made after a thorough assessment of his prostate and cardiovascular health, ensuring that he was fit for this less invasive treatment approach.
The Procedure and Outcome
The Rezūm procedure was performed in an outpatient setting under local anesthesia. Steam was delivered to specific areas of the prostate, targeting the enlarged tissue. The patient tolerated the procedure well, with minimal discomfort.
At his follow-up visit, the patient reported a marked improvement in symptoms, including a reduction in nocturia and better urinary flow. From a urological perspective, the outcomes were favorable, with no complications arising during or after the procedure. Importantly, the patient did not experience any adverse effects related to his cardiac disease, confirming the procedure's safety in patients with comorbidities.
Why the Rezūm Procedure is Ideal for Patients with Cardiac Disease
For patients with cardiac disease, the Rezūm procedure offers several key advantages:
- Minimally Invasive: The procedure is performed under local anesthesia, avoiding the risks associated with general anesthesia, which can be especially concerning in patients with heart disease.
- Low Risk of Bleeding: Unlike TURP and other more invasive surgeries, Rezūm has a significantly lower risk of bleeding, a critical consideration for patients with cardiovascular disease who may be on anticoagulation therapy or have fragile vascular systems.
- Quick Recovery: The recovery time for Rezūm is considerably shorter compared to traditional surgical options. This allows patients to return to their normal activities with less downtime, an important consideration for elderly patients or those with multiple medical concerns.
- Effective Symptom Relief: The procedure provides excellent long-term symptom relief for BPH, improving urinary function and quality of life without the complications associated with more invasive surgery.
it's essential to recognize that untreated BPH can lead to complications such as acute urinary retention, which can have significant effects on kidney function. The Rezūm procedure provides a safer, more effective solution for these patients, reducing the risk of urinary retention and its associated renal impacts. Additionally, as Rezūm is minimally invasive and has a lower risk of complications, it helps protect kidney function by avoiding the more invasive treatments that may put additional stress on renal health.
Conclusion
The Rezūm procedure offers an innovative and minimally invasive approach to treating BPH, particularly in patients with cardiac comorbidities. By providing effective symptom relief without the risks associated with more invasive surgeries, Rezūm is an excellent treatment option for this patient group. As urologists, it is our responsibility to stay updated on the latest advancements in treatment, especially when managing patients with complex medical histories. The Rezūm procedure is an important tool in our arsenal for improving patient outcomes, particularly in those with comorbidities like cardiovascular disease.
Comments
Post a Comment